Resultats de la cerca - Pierre‐Emmanuel Morange

Refinar resultats
  1. 1
    Current knowledge on the genetics of incident venous thrombosis

    Current knowledge on the genetics of incident venous thrombosis per Pierre‐Emmanuel Morange, David‐Alexandre Trégouët

    Publicat 2013
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies

    What is currently known about the genetics of venous thromboembolism at the dawn of next generation sequencing technologies per David‐Alexandre Trégouët, Pierre‐Emmanuel Morange

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

    Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk per I. Juhan-Vague, Marie‐Christine Alessi, Alenka Mavri, Pierre‐Emmanuel Morange

    Publicat 2003
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Role of the interferons in CD64 and CD169 expressions in whole blood: Relevance in the balance between viral‐ or bacterial‐oriented immune responses

    Role of the interferons in CD64 and CD169 expressions in whole blood: Relevance in the balance between viral‐ or bacterial‐oriented immune responses per P Bourgoin, Géraldine Biéchelé, Inès Ait Belkacem, Pierre‐Emmanuel Morange, Fabrice Malergue

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    miR-421 and miR-30c Inhibit SERPINE 1 Gene Expression in Human Endothelial Cells

    miR-421 and miR-30c Inhibit SERPINE 1 Gene Expression in Human Endothelial Cells per Alexandre Marchand, Carole Proust, Pierre‐Emmanuel Morange, Anne‐Marie Lompré, David‐Alexandre Trégouët

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Maximizing the Power of Principal-Component Analysis of Correlated Phenotypes in Genome-wide Association Studies

    Maximizing the Power of Principal-Component Analysis of Correlated Phenotypes in Genome-wide Association Studies per Hugues Aschard, Bjarni J. Vilhjálmsson, Nicolas Greliche, Pierre‐Emmanuel Morange, David‐Alexandre Trégouët, Peter Kraft

    Publicat 2014
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    PAI-1 Produced Ex Vivo by Human Adipose Tissue Is Relevant to PAI-1 Blood Level

    PAI-1 Produced Ex Vivo by Human Adipose Tissue Is Relevant to PAI-1 Blood Level per Pierre‐Emmanuel Morange, Marie‐Christine Alessi, Monique Verdier, Daniel Casanova, G. Magalon, I. Juhan‐Vague

    Publicat 1999
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Influence of PAI-1 on Adipose Tissue Growth and Metabolic Parameters in a Murine Model of Diet-Induced Obesity

    Influence of PAI-1 on Adipose Tissue Growth and Metabolic Parameters in a Murine Model of Diet-Induced Obesity per Pierre‐Emmanuel Morange, H.R. Lijnen, Marie‐Christine Alessi, F Kopp, D Collen, I. Juhan‐Vague

    Publicat 2000
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronary syndrome

    High post‐treatment platelet reactivity identified low‐responders to dual antiplatelet therapy at increased risk of recurrent cardiovascular events after stenting for acute coronar... per T. Cuisset, Corinne Frère, Jacques Quilici, Franck Barbou, Pierre‐Emmanuel Morange, Thomas Hovasse, J‐L. BONNET, Marie‐Christine Alessi

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Thrombin-Activatable Fibrinolysis Inhibitor Antigen Levels and Cardiovascular Risk Factors

    Thrombin-Activatable Fibrinolysis Inhibitor Antigen Levels and Cardiovascular Risk Factors per I. Juhan-Vague, Jean‐François Renucci, M. Grimaux, Pierre‐Emmanuel Morange, J. Gouvernet, Y Gourmelin, Marie‐Christine Alessi

    Publicat 2000
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Stromal Cells Are the Main Plasminogen Activator Inhibitor-1-Producing Cells in Human Fat

    Stromal Cells Are the Main Plasminogen Activator Inhibitor-1-Producing Cells in Human Fat per Delphine Bastelica, Pierre‐Emmanuel Morange, B Berthet, Hélène Borghi, Odile Lacroix, Michel Grino, I. Juhan‐Vague, Marie‐Christine Alessi

    Publicat 2002
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.

    Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity. per Marie‐Christine Alessi, Delphine Bastelica, Pierre‐Emmanuel Morange, B Berthet, Isabelle Leduc, Monique Verdier, O Geel, I. Juhan-Vague

    Publicat 2000
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies

    The endothelial protein C receptor (PROCR) Ser219Gly variant and risk of common thrombotic disorders: a HuGE review and meta-analysis of evidence from observational studies per Jessica Dennis, Candice Y. Johnson, Adeniyi Samuel Adediran, Mariza de Andrade, John A. Heit, Pierre‐Emmanuel Morange, David‐Alexandre Trégouët, France Gagnon

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary Stenting

    Benefit of a 600-mg Loading Dose of Clopidogrel on Platelet Reactivity and Clinical Outcomes in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome Undergoing Coronary S... per Thomas Cuisset, Corinne Frère, Jacques Quilici, Pierre‐Emmanuel Morange, Lyassine Nait-Saïdi, Joseph Carvajal, Agnès Lehmann, M. Lambert, J Bonnet, Marie‐Christine Alessi

    Publicat 2006
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort

    Biological and genetic factors influencing plasma factor VIII levels in a healthy family population: results from the Stanislas cohort per Pierre‐Emmanuel Morange, David‐Alexandre Trégouët, Corinne Frère, Noémie Saut, Laurence Pellegrina, Marie‐Christine Alessi, Sophie Visvikis‐Siest, Laurence Tiret, I. Juhan‐Vague

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels

    Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels per Guillemette Antoni, Tiphaine Oudot‐Mellakh, Apostolos Dimitromanolakis, Marine Germain, William Cohen, Philip Wells, Mark Lathrop, France Gagnon, Pierre‐Emmanuel Morange, David‐Alexandre Trégouët

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  17. 17
    Plasma Biomarkers and Identification of Resilient Metabolic Disruptions in Patients With Venous Thromboembolism Using a Metabolic Systems Approach

    Plasma Biomarkers and Identification of Resilient Metabolic Disruptions in Patients With Venous Thromboembolism Using a Metabolic Systems Approach per Karl Fraser, Nicole C. Roy, Louisa Goumidi, Alexandre Verdu, Pierre Suchon, Felipe L. Valentim, David‐Alexandre Trégouët, Pierre‐Emmanuel Morange, Jean‐Charles Martin

    Publicat 2020
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study

    TLR4/Asp299Gly, CD14/C-260T, plasma levels of the soluble receptor CD14 and the risk of coronary heart disease: The PRIME Study per Pierre‐Emmanuel Morange, Laurence Tiret, Noémie Saut, G. Luc, Dominique Arveiler, Jean Ferrières, Philippe Amouyel, A. Evans, Pierre Ducimetière, François Cambien, I. Juhan‐Vague

    Publicat 2004
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Multilocus Genetic Risk Scores for Venous Thromboembolism Risk Assessment

    Multilocus Genetic Risk Scores for Venous Thromboembolism Risk Assessment per José Manuel Soria, Pierre‐Emmanuel Morange, Joan Vila, Juan Carlos Souto, Manel Moyano, David‐Alexandre Trégouët, José Mateo, Noémi Saut, Eduardo Salas, Roberto Elosúa

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders

    Glycoprotein IIb/IIIa Inhibitors Improve Outcome After Coronary Stenting in Clopidogrel Nonresponders per Thomas Cuisset, Corinne Frère, Jacques Quilici, Pierre‐Emmanuel Morange, Jean-Philippe Mouret, Laurent Bali, Pierre-Julien Moro, M. Lambert, Marie‐Christine Alessi, Jean Louis Bonnet

    Publicat 2008
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: